Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis

Introduction. Low molecular weight heparin (LMWH) is preferred for malignancy-associated venous thromboembolism (VTE). Many providers monitor LMWH with anti-Xa levels, despite little validation on correspondence with patient outcome. Methods. This is a retrospective, single institution study of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yentz, Sarah, Onwuemene, Oluwatoyosi A., Stein, Brady L., Cull, Elizabeth H., McMahon, Brandon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620379/
https://www.ncbi.nlm.nih.gov/pubmed/26543644
http://dx.doi.org/10.1155/2015/126975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620379/
https://www.ncbi.nlm.nih.gov/pubmed/26543644
http://dx.doi.org/10.1155/2015/126975

Ejemplares similares